Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 4Osteoporosis 3Prostatic Neoplasms 2Pain 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myocardial Ischemia 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Heart Diseases 1Disease Progression 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases, Metabolic 1Bone Diseases 1

Interventions

Lenalidomide 3capivasertib 2Bortezomib 2tivozanib 1Zoledronic Acid 1Vitamin D 1Temozolomide 1Radiotherapy 1Nivolumab 1Gemcitabine 1Fulvestrant 1Etoposide 1Dexamethasone 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1Calcium 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Disease Progression × Calcium × Clear all
NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡